NSAIDs: Old Drugs Reveal New Anticancer Targets
There is compelling evidence that nonsteroidal anti-inflammatory drugs (NSAIDs) and cyclooxygenase-2 selective inhibitors have antineoplastic activity, but toxicity from cyclooxygenase (COX) inhibition and the suppression of physiologically important prostaglandins limits their use for cancer chemop...
Saved in:
Main Authors: | Gary A. Piazza (Author), Adam B. Keeton (Author), Heather N. Tinsley (Author), Jason D. Whitt (Author), Bernard D. Gary (Author), Bini Mathew (Author), Raj Singh (Author), William E. Grizzle (Author), Robert C. Reynolds (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2010-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
NSAIDs and Cell Proliferation in Colorectal Cancer
by: Raj Ettarh, et al.
Published: (2010) -
First Generation of Antioxidant Precursors for Bioisosteric Se-NSAIDs: Design, Synthesis, and In Vitro and In Vivo Anticancer Evaluation
by: Sandra Ramos-Inza, et al.
Published: (2023) -
Editorial: NSAIDs Pharmacogenomics
by: José A. G. Agúndez, et al.
Published: (2021) -
Pharmacogenomics of NSAID-Induced Upper Gastrointestinal Toxicity
by: L. McEvoy, et al.
Published: (2021) -
NSAID-Gut Microbiota Interactions
by: Damian Maseda, et al.
Published: (2020)